Netherlands· NL-d46fd955c8f1
Maintelyte, oplossing voor infusie
A elektrolytlösungen mit kohlenhydraten product containing acetaat (c2h3o2-) + chloride (cl-) + glucose 1-water + kalium (k+), registered in Netherlands by Baxter B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Elektrolytlösungen mit kohlenhydraten is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BB02 (elektrolytlösungen mit kohlenhydraten), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Elektrolytlösungen mit kohlenhydraten · ATC B05BB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ACETAAT (C2H3O2-) + CHLORIDE (CL-) + GLUCOSE 1-WATER + KALIUM (K+)
- Manufacturer
- Baxter B.V.
- Country
- Netherlands (NL)
- ATC code
- B05BB02
- ATC class
- Elektrolytlösungen mit Kohlenhydraten
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id123450
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05BB02
Elektrolytlösungen mit kohlenhydraten, as other registers publish it.
- Canada(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- Canada(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- Canada(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USPBAXTER CORPORATION
- Canada(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- Canada(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USPBAXTER CORPORATION
- Canada(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- Canada(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- Canada0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USPB. BRAUN MEDICAL INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5216844-789d-4b10-94b8-13a9222a66ca GET /v1/drugs/c5216844-789d-4b10-94b8-13a9222a66ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123450_smpc.pdf",
"strength": null,
"atc_label": "Electrolytes With Carbohydrates",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123450",
"excipients": [
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"ACETAAT (C2H3O2-)",
"CHLORIDE (CL-)",
"GLUCOSE 1-WATER",
"KALIUM (K+)",
"KALIUMCHLORIDE (E 508)",
"MAGNESIUM (MG2+)",
"MAGNESIUMCHLORIDE 6-WATER (E 511)",
"NATRIUM (NA+)",
"NATRIUMACETAAT 3-WATER (E 262)",
"NATRIUMCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123450.pdf",
"authorised_at": "2019/05/13",
"procedure_number": "SE/H/0921/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "123450",
"additional_monitoring": "N"
}See everything about elektrolytlösungen mit kohlenhydraten.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.